Keloid

Scar Treatment Market Worth $63.4 Billion by 2030: P&S Intelligence

Retrieved on: 
Thursday, October 8, 2020
Organ systems, Healing, Scar, Dermatology, Skin, RTT, Cutaneous conditions, Keloid, Acne, Hypertrophic scar

Due to this factor, the global scar treatment market is projected to advance from $19.6 billion in 2019 to $63.4 billion in 2030, at a healthy 11.5% CAGR between 2020 and 2030.

Key Points: 
  • Due to this factor, the global scar treatment market is projected to advance from $19.6 billion in 2019 to $63.4 billion in 2030, at a healthy 11.5% CAGR between 2020 and 2030.
  • As the lockdowns implemented in response to COVID-19 have halted major manufacturing and sales operations, the scar treatment market is witnessing slow growth in 2020.
  • Browse report with detailed COVID-19 impact analysis on Scar Treatment Market Research Report: By Treatment Type (Topical, Surface, Laser, Injectable, Surgical), Scar Type (Atrophic and Acne Scar, Keloid and Hypertrophic Scar, Contracture Scar, Stretch Mark), End User (Home-Use, Hospitals, Dermatology Clinics) - Global Industry Analysis and Growth Forecast to 2030 @ https://www.psmarketresearch.com/market-analysis/scar-treatment-market
    North America has been the largest contributor to the scar treatment market for quite some time now.
  • During the next decade, the fastest growth will be witnessed in the scar treatment market of Asia-Pacific (APAC).

myScarTape Can Restore Normalcy and Confidence to a Life Disrupted by Scarring

Retrieved on: 
Wednesday, October 7, 2020
Healing, Scar, Keloid, Health, Medical specialties, Medicine, Hypertrophic scar

Available in three skin tones and two shapes, myScarTape mimics the elasticity of skin and is applied over the scar for long-lasting coverage, protection and remediation.

Key Points: 
  • Available in three skin tones and two shapes, myScarTape mimics the elasticity of skin and is applied over the scar for long-lasting coverage, protection and remediation.
  • Additionally, when applied to young scars, it can often reduce further scar growth by supporting and alleviating skin tension on the affected area.
  • "I see a lot of patients that have bad scars, generally keloids or hypertrophic [HTS] scars," he said.
  • We went through various innovation rounds to improve what we did and reached what we have nowmyScarTapean easy intervention that can restore people's lives and improve people's quality of life."

Global Keloids Pipeline Report 2020: Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook - ResearchAndMarkets.com

Retrieved on: 
Friday, July 24, 2020
Health, Pharmaceutical, Keloid, Drug pipeline, Pipeline

The "Keloids Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Keloids Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook" report has been added to ResearchAndMarkets.com's offering.
  • The Keloids pipeline Research Monitor, 2020 report is an analytical research study on the progress achieved by pipeline companies during the year along with its historical development, current status, and outlook.
  • This Keloids pipeline review explores high-potential early to late-stage pipeline projects with a continued focus on new insights, accelerated processes, and pipeline progression.
  • The competitive intelligence report on Keloids presents detailed insights into therapeutic drug pipeline development, industry news, deals, and analysis across the length and breadth of the Keloids pipeline.

Increasing Awareness About Treatment Methods and Favorable Reimbursement Policies are at Helm of Recent Growth of Global Scar Treatment Market

Retrieved on: 
Monday, March 9, 2020
Organ systems, Dermatology, Skin, Healing, Scar, Acneiform eruptions, Keloid, Hypertrophic scar, Acne, Silicone, Scar

Key Findings in the Research Report:

Key Points: 
  • Key Findings in the Research Report:
    The global scar treatment market is broadly segmented in terms of scar type, type of treatment, channel of distribution, and by region
    Based on type of scar, the global scar treatment market is segmented into contracture scars, hypertrophic scars and keloids, acne & atrophic scars, and others (stretch marks).
  • Among these, the segment of topical products is projected to account for a larger share in the global scar treatment market.
  • Gain business intelligence on global Scar Treatment Market by Treatment Type - Topical Products (Creams, Gels, Silicone Sheets, Others (Sprays, Oils, etc.
  • North America has been the leading segment of the global scar treatment market in recent years.

Increasing Awareness About Treatment Methods and Favorable Reimbursement Policies are at Helm of Recent Growth of Global Scar Treatment Market

Retrieved on: 
Monday, March 9, 2020
Organ systems, Dermatology, Skin, Healing, Scar, Acneiform eruptions, Keloid, Hypertrophic scar, Acne, Silicone, Scar

Key Findings in the Research Report:

Key Points: 
  • Key Findings in the Research Report:
    The global scar treatment market is broadly segmented in terms of scar type, type of treatment, channel of distribution, and by region
    Based on type of scar, the global scar treatment market is segmented into contracture scars, hypertrophic scars and keloids, acne & atrophic scars, and others (stretch marks).
  • Among these, the segment of topical products is projected to account for a larger share in the global scar treatment market.
  • Gain business intelligence on global Scar Treatment Market by Treatment Type - Topical Products (Creams, Gels, Silicone Sheets, Others (Sprays, Oils, etc.
  • North America has been the leading segment of the global scar treatment market in recent years.

Soliton To Announce Keloid and Hypertrophic Scar Clinical 12-Week Trial Data at Maui Derm Meeting

Retrieved on: 
Monday, January 13, 2020
Medicine, Branches of biology, Medical specialties, Healing, Keloid, Scar, Hypertrophic scar, Fibrosis, Wound healing, Maui

The meeting is being held from January 25-29, 2020, in Maui Hawaii.

Key Points: 
  • The meeting is being held from January 25-29, 2020, in Maui Hawaii.
  • "There was an average reduction in the volume of the scars treated of 27% at the 6-week timepoint.
  • Fibrotic scars, such as keloid and hypertrophic scars, represent wound healing gone awry.
  • Grand View Research estimates the global market for keloid and hypertrophic scars may reach $10.2 billion by 2025.

Soliton Announces Successful Completion of Safety Testing at SGS to Support FDA Filing for Second Generation Device

Retrieved on: 
Wednesday, December 18, 2019
Keloid, Scar, Tattoo, Decades, Health, Units of time

This safety testing is a requirement of the supplemental 510(k) filing for the Company's RAP device for tattoo removal, improvement in the appearance of cellulite, keloid (scarring) and additional pipeline indications.

Key Points: 
  • This safety testing is a requirement of the supplemental 510(k) filing for the Company's RAP device for tattoo removal, improvement in the appearance of cellulite, keloid (scarring) and additional pipeline indications.
  • Dr. Chris Capelli, Soliton's President, CEO and co-founder, commented, "We are pleased, but not surprised by the safety testing results of our RAP device.
  • The safety of our second generation device mirrors that of our first, and these results reinforce this.
  • We look forward to submitting this safety data in early 2020, simultaneous with the Special 510k filing of our second generation RAP device.

$37.9 Bn Scar Treatment (Atrophic, Hypertrophic & Keloid Scars, Stretch Marks) Markets, 2019 - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 13, 2019
Health, General Health, Organ systems, Healing, Scar, Dermatology, Skin, Acneiform eruptions, Cutaneous conditions, RTT, Keloid, Acne

The "Scar Treatment Market Size, Share & Trends Analysis Report By Scar Type (Atrophic, Hypertrophic & Keloid Scars, Stretch Marks), By Product (Injectables, Topical, Laser), By End Use, And Segment Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Scar Treatment Market Size, Share & Trends Analysis Report By Scar Type (Atrophic, Hypertrophic & Keloid Scars, Stretch Marks), By Product (Injectables, Topical, Laser), By End Use, And Segment Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering.
  • The global scar treatment market size is expected to reach a value of USD 37.9 billion by 2026 registering a CAGR of 9.9%, according to this report.
  • Scar treatment market is developing at a fast rate due to the growing awareness among people regarding aesthetics.
  • For instance, UltraPulse by Lumenis uses CO2 laser for the treatment of acne scars reduces the risk of pain during the treatment process.

Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results

Retrieved on: 
Monday, October 21, 2019
Branches of biology, Healing, Medicine, Keloid, Medical specialties, Scar, Hypertrophic scar, Wound healing

A press release will make the data broadly available at 8:00 a.m.

Key Points: 
  • A press release will make the data broadly available at 8:00 a.m.
  • ET on October 25, 2019, and a follow-up webcast will be held October 25, 2019, at 5:30 p.m.
  • Keloid and hypertrophic scars (also referred to as fibrotic scars) represent wound healing gone awry.
  • Grand View Research estimates the global market for keloid and hypertrophic scars may reach $10.2 billion by 2025.

Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019

Retrieved on: 
Tuesday, October 8, 2019
Keloid, Scar, Hypertrophic scar, Health, Medicine, Medical specialties

We view this proof-of-concept trial as the starting point for demonstrating that our technology could impact other fibrotic disorders.

Key Points: 
  • We view this proof-of-concept trial as the starting point for demonstrating that our technology could impact other fibrotic disorders.
  • The same mechanism of action at work to reduce keloid and hypertrophic scars could likely extend to such indications as capsular contraction, Peyrone's Disease, and even liver fibrosis."
  • The American Osteopathic College of Dermatology estimates that keloids affect around 10 percent of people, whereas hypertrophic scars are more common.
  • Grand View Research estimates the global market for keloid and hypertrophic scars may reach $10.2 billion by 2025.